No Picture
Trading Ideas

Wells Fargo (WFC) Has Fallen 49% in Last One Year, Underperforms Market

If you are looking for the best ideas for your portfolio you may want to consider some of Saber Capital Management’s top stock picks. Saber Capital Management, an investment management firm, is bullish on Wells Fargo & Company (NYSE:WFC) stock. In its Q2 2019 investor letter – you can download a copy here – the […] …read more […]

No Picture
Trading Ideas

Apple Prepares to Launch 5G iPhones Into Unready U.S. Market

(Bloomberg) — Apple Inc. is set to embrace 5G as one of its most significant additions to this year’s iPhones, but the technology is still not ready for the masses in the U.S.That’s because the country’s three largest wireless carriers, Verizon Communications Inc., AT&T Inc. and T-Mobile US Inc., have yet to roll out 5G in a way that provides consistently higher data speeds or widespread coverage. If these companies do not dramatically upgrade their networks soon, many consumers buying the latest iPhones could find this year’s premier feature underwhelming.The addition of 5G will be a key talking point at …read more […]

No Picture
Trading Ideas

3 Stocks Under $5 That Could Deliver Triple-Digit Wins

Investing is all about profits and returns – no one puts their money into a stock without an expectation that the investment will make money. The trick, if there is one, is finding the stocks that deliver the best returns.There’s a tendency to want to jump on the bandwagons, to buy into the big names that have grabbed the headlines. And that can bring in profits – there is no doubt that Amazon and Tesla have shown astounding growth in recent months.But there is also profit and potential to be found under the radar, in smaller stocks with lower price. …read more […]

No Picture
Trading Ideas

Pfizer's breast cancer drug Ibrance fails late-stage study

The latest development comes after an independent data monitoring committee said in May a similar trial comparing Ibrance plus an endocrine therapy to a standalone endocrine therapy to treat early-stage breast cancer was unlikely to meet the main goal. Ibrance is already approved in the United States to treat certain adult patients with advanced breast cancer which has spread to other parts of the body. …read more […]